XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
XORTX Therapeutics Inc. has appointed Dr. Michael Bumby as the new Chief Financial Officer, bringing his extensive experience in finance and leadership within the biotech and pharma industries. The appointment is expected to provide strategic financial guidance to the company as it advances its clinical development programs.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
